论文部分内容阅读
在近年来全球医药市场持续快速增长的大环境下,受益于人口老龄化、疾病图谱变化和居民消费升级等因素,国内大健康产业发展再次提速。2016年我国医药工业实现主营业务收入28063亿元,同比增长9.7%,与上年相比提升0.6个百分点,高于全国工业增速(4.9%)4.8个百分点;医药行业实现利润总额突破3000亿元,同比增长13.9%,与上年相比提升1个百分点,高于全国工业增速(8.5%)5.4
In recent years, the global pharmaceutical market continues to grow rapidly under the macro-environment, benefiting from the aging population, changes in disease patterns and the upgrading of household consumption and other factors, the rapid development of the domestic large-scale health industry. In 2016, China’s pharmaceutical industry achieved a revenue of 2,806.3 billion yuan from main operations, an increase of 9.7% over the same period of previous year, an increase of 0.6 percentage point from the previous year and 4.8 percentage points higher than the national industrial growth rate (4.9%). The total profit of the pharmaceutical industry exceeded 3,000 100 million yuan, up 13.9% from the same period of last year, 1 percentage point higher than the previous year, higher than the national industrial growth rate of 8.5% 5.4